News + Filings Transactions Holdings
|
ESHELMAN FREDRIC N
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/23/2022 | Aravive, Inc. | ARAV | Grant | Stock Option (Right to Buy) | 97.1k | $0.92 | $88.8k | | 09/23/2022 |
| 04/01/2022 | Aravive, Inc. | ARAV | Exercise | Pre-Funded Warrant (right to buy) | 4.5M | $0.00 | $454.5 | See footnote | 04/01/2022 |
| 01/03/2022 | Aravive, Inc. | ARAV | Grant | Pre-Funded Warrant (right to buy) | 4.5M | $0.00 | $454.5 | See footnote | 01/03/2022 |
| 11/17/2021 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 7k | $0.00 | $0 | | 11/17/2021 |
| 11/17/2021 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 9.7k | $3.59 | $34.7k | | 11/17/2021 |
| 09/10/2021 | Aravive, Inc. | ARAV | Grant | Stock Option | 22.8k | $3.97 | $90.6k | | 09/10/2021 |
| 02/12/2021 | Aravive, Inc. | ARAV | Grant | Common stock | 2.9M | $7.29 | $21M | See Footnote | 02/12/2021 |
| 09/14/2020 | Aravive, Inc. | ARAV | Grant | Stock Option | 16k | $5.63 | $90.2k | | 09/14/2020 |
| 09/11/2020 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 7.3k | $0.00 | $0 | | 09/11/2020 |
| 09/11/2020 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 9.8k | $3.43 | $33.7k | | 09/11/2020 |
| 06/11/2020 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $17.59 | $351.8k | | 06/11/2020 |
| 06/01/2020 | Aravive, Inc. | ARAV | Grant | Stock Option | 7.5k | $12.72 | $95.4k | | 06/01/2020 |
| 06/01/2020 | Aravive, Inc. | ARAV | Grant | Stock Option | 3.2k | $12.72 | $41k | | 06/01/2020 |
| 08/16/2019 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 9.1k | $3.11 | $28.2k | | 08/16/2019 |
| 08/16/2019 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 8k | $0.00 | $0 | | 08/16/2019 |
| 06/12/2019 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $18.47 | $369.4k | | 06/12/2019 |
| 07/24/2018 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 4.5k | $6.20 | $27.7k | | 07/24/2018 |
| 07/24/2018 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 4k | $0.00 | $0 | | 07/24/2018 |
| 06/07/2018 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 10k | $38.39 | $383.9k | | 06/07/2018 |
| 05/31/2018 | MEDICINES CO /DE | MDCO | Grant | Common Stock | 3.8k | $0.00 | $0 | | 05/31/2018 |
| 05/31/2018 | MEDICINES CO /DE | MDCO | Grant | Stock Option (right-to-buy) | 14.1k | $33.86 | $478.8k | | 05/31/2018 |
| 01/29/2018 | EYENOVIA, INC. | EYEN | Purchase | Common Stock, par value $.0001 | 335k | $10.00 | $3.4M | | 01/29/2018 |
| 12/08/2017 | MEDICINES CO /DE | MDCO | Purchase | Common Stock | 100k | $26.65 | $2.7M | | 12/07/2017 |
| 12/07/2017 | MEDICINES CO /DE | MDCO | Purchase | Common Stock | 100k | $26.46 | $2.6M | | 12/07/2017 |
| 11/13/2017 | G1 Therapeutics, Inc. | GTHX | Purchase | Common Stock | 250k | $19.73 | $4.9M | | 11/13/2017 |
| 07/11/2017 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $15.55 | $311k | | 07/11/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Purchase | Common Stock | 300k | $15.00 | $4.5M | See Footnote | 05/22/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Series B Preferred Stock | 6.9M | $0.00 | $0 | See Footnote | 05/22/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Series C Preferred Stock | 2.5M | $0.00 | $0 | See Footnote | 05/22/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Common Stock | 3.1M | $0.00 | $0 | See Footnote | 05/22/2017 |
| 05/12/2016 | MEDICINES CO /DE | MDCO | Purchase | Common Stock | 300k | $33.68 | $10.1M | | 05/12/2016 |
| 06/01/2012 | Furiex Pharmaceuticals, Inc. | FURX | Purchase | Common Stock | 50.3k | $19.72 | $992.3k | | 05/31/2012 |
| 05/31/2012 | Furiex Pharmaceuticals, Inc. | FURX | Purchase | Common Stock | 70.1k | $20.06 | $1.4M | | 05/31/2012 |
| 05/30/2012 | Furiex Pharmaceuticals, Inc. | FURX | Purchase | Common Stock | 96.3k | $19.87 | $1.9M | | 05/29/2012 |
| 05/29/2012 | Furiex Pharmaceuticals, Inc. | FURX | Purchase | Common Stock | 72.4k | $19.96 | $1.4M | | 05/29/2012 |
|
|